Holland & Barrett still at till with LBO financing

All eyes in the leveraged loan market this week were trained on UK health food retailer Holland & Barrett.

  • By Max Bower
  • 10 Aug 2017


The firm has shifted some £100m-equivalent from a £550m term loan to a €275m-equivalent term loan, widening pricing and extending the commitments deadline in the process.

Investors had voiced concern over the aggressive nature of the deal — leverage stands at more than 5.5 times Ebitda — and ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bookrunners of European Leveraged Loans

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 27,131.20 86 8.49%
2 BNP Paribas 21,328.50 125 6.68%
3 Goldman Sachs 16,576.80 68 5.19%
4 Deutsche Bank 15,107.77 87 4.73%
5 HSBC 14,990.50 96 4.69%

Bookrunners of European HY Bonds

Rank Lead Manager Amount €m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 8,469.76 69 8.01%
2 Goldman Sachs 8,116.84 64 7.67%
3 Credit Suisse 6,908.88 70 6.53%
4 Deutsche Bank 6,384.59 62 6.04%
5 BNP Paribas 5,941.97 66 5.62%

Bookrunners of Dollar Denominated HY Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 JPMorgan 37,132.38 289 10.73%
2 Citi 29,048.74 232 8.39%
3 Bank of America Merrill Lynch 28,989.38 252 8.38%
4 Goldman Sachs 24,953.24 183 7.21%
5 Barclays 23,148.60 155 6.69%